Novo-Nordisk A/S News

6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons

Nov 7 15:08 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Nov 5 09:31 ET

6-K: Publication of New Total Number of Voting Rights According to Sec. 41 WpHG

Nov 1 09:27 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Oct 28 08:53 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Oct 21 10:40 ET

6-K: Oral Semaglutide Demonstrates a 14% Reduction in Risk of Major Adverse Cardiovascular Events in Adults with Type 2 Diabetes in the SOUL Trial

Oct 21 08:34 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Oct 15 06:18 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Oct 7 07:58 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Sep 30 08:03 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Sep 24 09:06 ET

6-K: Monlunabant Phase 2a Trial in Obesity Successfully Completed

Sep 20 09:52 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Sep 16 13:32 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Sep 9 11:15 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Sep 9 11:10 ET

6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons

Aug 30 10:17 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Aug 26 10:46 ET

6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons

Aug 21 06:05 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Aug 19 09:22 ET

6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons

Aug 14 08:29 ET

6-K: Novo Nordisk A/S - Share Repurchase Programme

Aug 12 09:50 ET